1. OUR FOCUS: UN POLITICAL DECLARATION TARGET No. 4

2. 54% of all people eligible were receiving antiretroviral therapy in low- and middle-income countries in 2011 Percentage receiving ART in 2011. Legend Source: UNAIDS, 2012 Number of people eligible for antiretroviral therapy.

3. Return for investment Sources: Bärnighausen T et al, The economic benefits of ART: evidence from a complete population cohort in rural South Africa 2nd International HIV Workshop on Treatment as Prevention, Vancouver, Canada, April 2012. Before treatment After starting treatment Likelihood of employment before and after starting antiretroviral therapy KwaZulu-Natal, South Africa

4. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009 Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

5. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009 To improve testing:  Reduce stigma in the community and in healthcare settings  Strengthen community support and referral networks  Enhance human rights literacy Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

6. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009 Improve enrolment in care:  Expand community-centred delivery  Overcome cost & transport barriers  Enhance treatment & rights literacy Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

7. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009 Get more people on treatment:  Enhance peer support programmes  Reduce costs  Overcome transport barriers  Ensure adequate nutrition  Reduce stigma in healthcare settings Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care

8. Percentage of people retained in treatment and care after diagnosis, USA and Mozambique Source: Gardner E M et al. Clin Infect Dis. 2011;52:793-800; Micek et al JAIDS 2009 Retain people on treatment:  Adherence support programmes  Reduce gender inequalities  Reduce fear of disclosure  Overcome cost and transport barriers  Referral and support programmes for migrants Tested <30 days Mozambique USA Diagnosed with HIV Linked/ enrolled in care Eligible for ART Initiated ART Adherent or undetectable Retained in care 100% 0 Retained in treatment and care